Research Helping the Cancer Survivor

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center is leading the way in new research initiatives addressing issues faced by cancer survivors. Guadalupe Palos, M.S.W., Dr.P.H., Manager of the Office of Cancer Survivorship at MD Anderson, explains the importance of funding cancer survivor research and discusses current studies investigating ways to reduce treatment side effects. Jason Cox is a childhood cancer survivor of rhabdomyosarcoma and is now a successful attorney. Cox discusses his...

CYCORE – Information Technology Tools Helping With Clinical Trials

submitted by: mdanderson
CYCORE (Cyberinfrastructure for Comparative Effectiveness Research) was a clinical trial conducted by The University of Texas MD Anderson Cancer Center, University of California-San Diego and University of Alabama at Birmingham, that studied the use of sensing devices to wirelessly send health-related data from the patient’s home to the cancer research facility. The purpose of this study is for other researchers to use CYCORE’s technology to gather more detailed information in their own...

Targeted Drug Melts Fat in Obese Monkeys

submitted by: mdanderson
An anti-obesity drug that homes in on and destroys blood vessels that support fat reduced the weight of obese rhesus monkeys by 11 percent in one month. It also trimmed their waistlines by eradicating 27 percent of their abdominal fat. Obesity raises a person's risk for developing breast, ovarian, prostate, colon and other cancers and also hinders treatment for cancer patients. Scientists at The University of Texas MD Anderson Cancer Center who developed the drug discuss results of the...

Body Image Issues for Cancer Patients

submitted by: mdanderson
Download from iTunes: Michelle C. Fingeret, Ph.D., Assistant Professor in the Department of Behavioral Science with joint appointments in the Departments of Plastic Surgery and Head and Neck Surgery at the University of Texas MD Anderson Cancer Center discusses her innovative line of research.

Targeted Lymphoma Drug Works After Others Fail

submitted by: mdanderson

MD Anderson's Dr. Michelle Fanale, Hodgkin lymphoma survivor Alexandra Medina and research nurse Rinata Simien talk about newly approved drug brentuximab vedotin.

DIRICOM Research Project

submitted by: neo

This video presents the DIRICOM Research Project. One of the goals inside this Project is to design a wireless system network that allows the communication among cars (the so-called Vehicular Ad-hoc Network or VANETs). For more information, please visit: DIRICOM web site

iDASH Internship Symposium Welcome

submitted by: ucsd_idash

iDASH Internship Symposium Welcome by Dr. Lucila Ohno Machado.

Hope on the Horizon for Pancreatic Cancer Patients

submitted by: mdanderson
Clinical Trial: Milind Javle, M.D., associate professor in the Department of Gastrointestinal Medical Oncology at MD Anderson Cancer Center, is offering hope for those faced with pancreatic cancer. Javle is leading a new clinical trial which targets the rapid growth of pancreatic cancer cells. This trial is testing the standard treatment with a new antibody that has shown promising results in the laboratory. Javle says it is believed that every pancreatic...

'GlyphSea': A New Way to Visualize Vector Data

submitted by: btolo

Researchers at the San Diego Supercomputer Center (SDSC) and other organizations within the University of California, San Diego, have developed a novel way to encode and display vector data that clearly shows magnitude and direction. This new visualization technique may help seismologists to accurately analyze ground movements for an earthquake, measure magnetic turbulence in deep space, or allow medical researchers to study areas such as blood flow and nutrient absorption.

Antibiotic resistant hospital bacteria

submitted by: COMED2010
MOSAR aims to significantly advance our knowledge regarding the control of antimicrobial resistance of bacteria responsible for major and emerging nosocomial diseases in hospitals, which are now spreading into communities. MOSAR will examine the factors determining the dynamics of spread of AMRB within healthcare facilities and the relative efficacity and medicoeconomic impact of control strategies. The resulting new knowledge will be disseminated to caregivers and health policy makers and...